daily

Interview: Med Ed 101: Dr. Eric Christianson

By: Tasnima Nabi, Copy Editor [Content-Focused] - Social media is a powerful platform, allowing for the quick and easy exchange…

12 years ago

Off-Label Antidepressant Use in Pediatric Patients with Autism

By: Jacqueline Meaney, PharmD Candidate c/o 2015, University at Buffalo: School of Pharmacy and Pharmaceutical Sciences -- Psychotropic medications are…

12 years ago

Meet the Air Force: Dr. Joanne Bollhofer-White

By: Melissa Roy Co-Copy Editor [Graphics focused] -- Many people do not realize the opportunities that are available to pharmacists.…

12 years ago

The Silver Age of Antibiotics

By: Andrew Leong, Staff Writer -- This year, the FDA approved three new antibiotics to treat acute bacterial skin and…

12 years ago

Pradaxa® vs Warfarin

By: Kevin Lin, PharmD Candidate c/o 2015 -- The FDA recently completed an observational cohort study that compared Pradaxa® (dabigatran)…

12 years ago

FDA-Approved Afrezza: An Inhaled Alternative to Injectable Insulin?

By: Elissa Tam, PharmD Candidate c/o 2015 - Patients with Type 1 or Type 2 diabetes who cannot control their…

12 years ago

HIV Pre-Exposure Prophylaxis

By: Elissa Tam PharmD Candidate c/o 2015 - HIV/AIDS continues to be a persistent problem in the United States and…

12 years ago

Pediatric Hypertension

By: Anthony Botte and Tyler Valente, PharmD Candidates c/o 2016 - Diseases which are prevalent within the pediatric population require…

12 years ago

Migraine Relief at the Push of a Button

By: Davidta Brown, Senior Staff Editor - A new therapeutic device has seemingly leapt from the pages of a science…

12 years ago

Recent Advances in HIV Treatment

By: Jenny Park PharmD Candidate c/o 2015 - A series of broad HIV specific monoclonal antibodies (mAb) have been isolated…

12 years ago

Grastek®: FDA Approves New Sublingual Immunotherapy for Allergies

By: Kevin Lin, PharmD Candidate c/o 2015 - This April, the FDA approved three sublingual immunotherapies for pollen induced allergic…

12 years ago

The Dangers of Intrathecal Baclofen

By: Ada Seldin, Staff Editor - Intrathecal baclofen (ITB) is indicated for the treatment of intractable spasticity caused by spinal…

12 years ago

The Use of Topical Opioid Treatment for Pressure Ulcer Wounds

By: Katharine Cimmino, Editor-in-Chief - Pressure ulcers can be a painful condition decreasing the quality of life of patients and…

12 years ago

Brown-Bag Event

By: Hayeon Na, Co-Copy Editor (Content Focused) - On February 26th, 2014, pharmacists, clinical faculty, and pharmacy students from St.…

12 years ago

Riociguat (Adempas®) New Drug for Pulmonary Hypertension

By: Hayeon Na, Co-Copy Editor [Content-Focused] - On October 8th of 2013, Bayer’s new drug riociguat (Adempas®) was approved for…

12 years ago

Tasimelteon (Hetlioz®): First FDA Approved Pharmacologic Agent for Treatment of Non-24 in Completely Blind Individuals

By: Beatrisa Popovitz, Senior Staff Editor - On January 31st 2014, the FDA announced the release of a revolutionary new…

12 years ago

Dietary Supplements and Their Potential Dangers

By: Fatema Elias, Staff Writer - With the New Year and everyone committing to their New Year resolutions, more and…

12 years ago

The Importance of Organ Donation: Perspectives and the Lives Affected

By: James Schurr, PharmD Candidate c/o 2014 and Jennifer Miao, PharmD Candidate c/o 2014 With very special thanks to Jessica…

12 years ago

A Walk To Remember

By: Caitie Stehling, PharmD Candidate c/o 2015 - St. John’s University is grounded in its Catholic, Vincentian, and Metropolitan mission.…

12 years ago

Low Literacy and Medication Management?

By: Jenny Park, Pharm. D. Candidate c/o 2015 - As the Affordable Care Act brings health care to many people…

12 years ago

Pharmacy Across the Border: An Interview with Sherif Guorgui, VP of Pharmacy at the Ontario Pharmacists Association

By: Sang Hyo Kim, Staff Editor - For the brand new year, we present an interview with Sherif Guorgui, the…

12 years ago

Surviving APPE Rotations

By: Aleena Cherian, Co-Copy Editor [Graphics-Focused] and Jenny Prakash, PharmD Candidate c/o 2014 - Starting your rotations in 5th year…

12 years ago

New Alternative First Line Therapy for EGFR NSCLC

By: Jenny Park, PharmD Candidate c/o 2015 - On July 12, 2013, the FDA approved afatinib (GilotrifTM) as a new…

12 years ago

New Hepatitis C Drug Receives FDA Approval

By: Ada Seldin, Staff Editor - On November 22, 2013, simeprevir (Olysio®), a new agent to treat chronic hepatitis C,…

12 years ago

The Use of Methadone in Neuropathic Pain

By: Neal Shah, PharmD, MD/PhD Student c/o 2021, West Virginia University School of Medicine - Methadone is a powerful long-acting…

12 years ago

The Blunt Truth

By: Katharine Cimmino, Editor-in-Chief - Marijuana, also known as “grass,” “pot,” “joint,” “weed,” “reefer,” “hashish,” and “Mary Jane,” is a…

12 years ago

Newly Approved: Macitentan (Opsumit®)

By: Rebecca Gilene, PharmD Candidate c/o 2014, St. Louis College of Pharmacy - The FDA approved macitentan (Opsumit®) on October…

13 years ago

Ponatinib Taken Off the Market

By: Sherine Jaison, PharmD Candidate c/o 2015 -  The leukemia chemotherapy drug ponatinib (Iclusig) has just been taken off the…

13 years ago

Still a Long Road Ahead for New Hepatitis C Treatment

By: Ramya Mathew, PharmD Candidate c/o 2015 - Vertex Pharmaceuticals, an American biotechnology company based in Cambridge, Massachusetts, has been…

13 years ago

Possible Mandatory Lung Cancer Screening

By: Jenny Park, PharmD Candidate c/o 2015 - Lung cancer takes away the lives of about 160,000 individuals annually, which…

13 years ago

Moving Towards Provider Status: An Interview with Sandra Leal

By: Hayeon Na, Co-Copy Editor and Sang Hyo Kim, Staff Editor - In Volume 1 Issue1 of the Rho Chi…

13 years ago

Does Moxifloxacin Increase the Risk of Dysglycemia?

By: Nathan Trustman, PharmD Candidate c/o 2014, AMSCOP at LIU - The antibiotic class known as the fluoroquinolones is widely…

13 years ago

New Drug to Treat HIV-1 Hits the Market

By: Ada Seldin, Staff Editor - On August 12,2013, a new weapon against HIV-1 infection was added to the existing…

13 years ago

Canagliflozin (Invokana®): New Type 2 Diabetes Drug

By: Sang Hyo Kim, Staff Editor - On March 29th 2013, the U.S Food and Drug Administration approved canagliflozin (Invokana®),…

13 years ago

iPod, iPad, iPhone… iLimb

By: Sang Hyo Kim, Staff Editor - There is a new invention called “i-limb ultra revolution,” which allows amputees to…

13 years ago

Comparison of the New Oral Antithrombotics and Warfarin

By Omar Khalid Pharm.D. Candidate c/o 2014 - The outpour of a multitude of new oral anticoagulants in recent years…

13 years ago

Two New Agents for the Treatment of Obesity

By: Nathan Trustman, PharmD Candidate c/o 2013, AMSCOP at LIU - Obesity is defined as having a body mass index…

13 years ago

Solving the HCV Enigma: Current and Future Drug Therapy for Hepatitis C

By: Tamara Yunusova, Senior Staff Editor - Approximately 3.2 million Americans have chronic hepatitis C infection.1 While acute cases are…

13 years ago

Compounding at a Crossroads: New Boundaries in the Aftermath of Tragedy?

Davidta Brown, PharmD Candidate c/o 2017 -      The debate on the nature of compounding practice and the extent to…

13 years ago

FDA Approves Dimethyl Fumarate for Treatment of Relapsing Forms of Multiple Sclerosis

By: Andy Zhang, PharmD Candidate c/o 2015 - On March 28, 2013, the U.S. Food and Drug Administration announced the…

13 years ago

Alzheimer’s Disease On The Rise

By: Ada Seldin - An impending storm is threatening to stagger the health care system and the nation at large.…

13 years ago

FDA Approves New Drug ‘Tofacitinib’ for Rheumatoid Arthritis

By: Erica Dimitropoulos, Senior Staff Editor - Rheumatoid arthritis is a painful and often debilitating autoimmune disease characterized by symmetric…

13 years ago

New FDA Approval: Fycompa® to Treat Seizures

By: Bhavini Shah, PharmD Candidate c/o 2013  - Fycompa® (perampanel) has received the U.S. Food and Drug Administration (FDA) approval…

13 years ago

FDA Approves New Indication for Botox (OnabotulinumtoxinA) for Urinary Incontinence

By: Bethsy Jacob, PharmD Candidate 2014 - On January 18, 2013, the U.S. Food and Drug Administration (FDA) announced a…

13 years ago

Calcium Intake and Risk of Myocardial Infarction

By:  Lila Ahmed, PharmD Candidate c/o 2013 - In the past, numerous research efforts have attempted to prove the benefits…

13 years ago

Liraglutide (Victoza®) for Type 2 Diabetes Mellitus

By:  Miriam Maltz, PharmD Candidate c/o 2013, AMSCOP, Long Island University - Type 2 diabetes mellitus (T2DM) is a metabolic…

13 years ago

The Opioid Debate: PROP and PROMPT Battle Away

By: Tamara Yunusova - On Wednesday, July 25th a petition signed by the reform group Physicians for Responsible Opioid Prescribing…

13 years ago

FDA Approves Apixaban For Nonvalvular Atrial Fibrillation

By: Alexandra Alleva, PharmD candidate c/o 2013 - As of December 28th, Bristol-Myers Squibb and Pfizer's brand name oral anticoagulant,…

13 years ago

Safety and Efficacy of Atropine for Salivary Hypersecretion

By: Elsa Thomas, PharmD Candidate c/o 2013 - Atropine is an anticholinergic used to treat various conditions, such as bradycardia,…

14 years ago

New Drug Review: Tofacitinib (Xeljanz®)

By: Jessica Lee, PharmD Candidate c/o 2013 - Rheumatoid arthritis (RA) is an autoimmune disease in which the immune system…

14 years ago